QIAGEN N.V. (QGEN) Stock Fundamental Analysis
NYSE:QGEN - New York Stock Exchange, Inc. - NL0015002CX3 - Common Stock - Currency: USD
Taking everything into account, QGEN scores 6 out of 10 in our fundamental rating. QGEN was compared to 55 industry peers in the Life Sciences Tools & Services industry. QGEN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QGEN has a decent growth rate and is not valued too expensively. These ratings would make QGEN suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year QGEN was profitable.
In the past year QGEN had a positive cash flow from operations.
Each year in the past 5 years QGEN has been profitable.
In the past 5 years QGEN always reported a positive cash flow from operatings.
1.2 Ratios
QGEN's Return On Assets of 1.47% is fine compared to the rest of the industry. QGEN outperforms 72.73% of its industry peers.
QGEN's Return On Equity of 2.34% is fine compared to the rest of the industry. QGEN outperforms 70.91% of its industry peers.
QGEN has a Return On Invested Capital of 7.14%. This is in the better half of the industry: QGEN outperforms 78.18% of its industry peers.
QGEN had an Average Return On Invested Capital over the past 3 years of 7.25%. This is significantly below the industry average of 13.60%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROIC | 7.14% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
QGEN has a Profit Margin of 4.23%. This is in the better half of the industry: QGEN outperforms 72.73% of its industry peers.
QGEN's Profit Margin has declined in the last couple of years.
QGEN's Operating Margin of 25.02% is amongst the best of the industry. QGEN outperforms 94.55% of its industry peers.
QGEN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 63.82%, QGEN belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
QGEN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QGEN is destroying value.
Compared to 1 year ago, QGEN has less shares outstanding
Compared to 5 years ago, QGEN has less shares outstanding
QGEN has a better debt/assets ratio than last year.
2.2 Solvency
QGEN has an Altman-Z score of 4.51. This indicates that QGEN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of QGEN (4.51) is better than 80.00% of its industry peers.
The Debt to FCF ratio of QGEN is 2.77, which is a good value as it means it would take QGEN, 2.77 years of fcf income to pay off all of its debts.
QGEN's Debt to FCF ratio of 2.77 is fine compared to the rest of the industry. QGEN outperforms 80.00% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that QGEN is not too dependend on debt financing.
QGEN has a Debt to Equity ratio (0.38) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Altman-Z | 4.51 |
ROIC/WACC0.92
WACC7.72%
2.3 Liquidity
QGEN has a Current Ratio of 3.61. This indicates that QGEN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of QGEN (3.61) is comparable to the rest of the industry.
A Quick Ratio of 3.09 indicates that QGEN has no problem at all paying its short term obligations.
The Quick ratio of QGEN (3.09) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.95% over the past year.
QGEN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.25% yearly.
The Revenue has been growing slightly by 0.66% in the past year.
Measured over the past years, QGEN shows a small growth in Revenue. The Revenue has been growing by 5.32% on average per year.
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
3.2 Future
Based on estimates for the next years, QGEN will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.10% on average per year.
The Revenue is expected to grow by 7.82% on average over the next years.
EPS Next Y8.4%
EPS Next 2Y8.51%
EPS Next 3Y8.96%
EPS Next 5Y9.1%
Revenue Next Year4.26%
Revenue Next 2Y5.22%
Revenue Next 3Y5.83%
Revenue Next 5Y7.82%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 20.93 indicates a rather expensive valuation of QGEN.
Based on the Price/Earnings ratio, QGEN is valued a bit cheaper than 80.00% of the companies in the same industry.
QGEN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.53, which indicates a rather expensive current valuation of QGEN.
Based on the Price/Forward Earnings ratio, QGEN is valued cheaper than 81.82% of the companies in the same industry.
QGEN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.93 | ||
| Fwd PE | 18.53 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QGEN is valued cheaply inside the industry as 87.27% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, QGEN is valued cheaply inside the industry as 83.64% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.75 | ||
| EV/EBITDA | 14.7 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QGEN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of QGEN may justify a higher PE ratio.
PEG (NY)2.49
PEG (5Y)2.54
EPS Next 2Y8.51%
EPS Next 3Y8.96%
5. Dividend
5.1 Amount
QGEN has a yearly dividend return of 0.52%, which is pretty low.
QGEN's Dividend Yield is rather good when compared to the industry average which is at 0.50. QGEN pays more dividend than 92.73% of the companies in the same industry.
With a Dividend Yield of 0.52, QGEN pays less dividend than the S&P500 average, which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
5.2 History
QGEN is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.51%
EPS Next 3Y8.96%
48.13
-0.42 (-0.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners86.78%
Inst Owner Change0%
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap10.42B
Analysts76.67
Price Target50.38 (4.67%)
Short Float %2.65%
Short Ratio4.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.23%
Min EPS beat(2)-3.85%
Max EPS beat(2)3.38%
EPS beat(4)3
Avg EPS beat(4)1.13%
Min EPS beat(4)-3.85%
Max EPS beat(4)3.38%
EPS beat(8)5
Avg EPS beat(8)1.25%
EPS beat(12)9
Avg EPS beat(12)4.32%
EPS beat(16)13
Avg EPS beat(16)5.2%
Revenue beat(2)0
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.02%
Revenue beat(8)0
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.09%
Revenue beat(16)7
Avg Revenue beat(16)0.75%
PT rev (1m)0.46%
PT rev (3m)-0.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.65%
EPS NY rev (1m)0.31%
EPS NY rev (3m)2.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.93 | ||
| Fwd PE | 18.53 | ||
| P/S | 5.27 | ||
| P/FCF | 20.75 | ||
| P/OCF | 15.47 | ||
| P/B | 2.92 | ||
| P/tB | 12.44 | ||
| EV/EBITDA | 14.7 |
EPS(TTM)2.3
EY4.78%
EPS(NY)2.6
Fwd EY5.4%
FCF(TTM)2.32
FCFY4.82%
OCF(TTM)3.11
OCFY6.46%
SpS9.13
BVpS16.47
TBVpS3.87
PEG (NY)2.49
PEG (5Y)2.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROCE | 9.62% | ||
| ROIC | 7.14% | ||
| ROICexc | 9.2% | ||
| ROICexgc | 29.06% | ||
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% | ||
| FCFM | 25.39% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Debt/EBITDA | 1.92 | ||
| Cap/Depr | 84.24% | ||
| Cap/Sales | 8.66% | ||
| Interest Coverage | 20.47 | ||
| Cash Conversion | 96.47% | ||
| Profit Quality | 600.91% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 | ||
| Altman-Z | 4.51 |
F-Score7
WACC7.72%
ROIC/WACC0.92
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
EPS Next Y8.4%
EPS Next 2Y8.51%
EPS Next 3Y8.96%
EPS Next 5Y9.1%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
Revenue Next Year4.26%
Revenue Next 2Y5.22%
Revenue Next 3Y5.83%
Revenue Next 5Y7.82%
EBIT growth 1Y11.16%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year58.48%
EBIT Next 3Y22.89%
EBIT Next 5Y16.26%
FCF growth 1Y69.33%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y46.6%
OCF growth 3Y1.77%
OCF growth 5Y15.28%